ArticleJournal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy2022

Successful use of casirivimab/imdevimab anti-spike monoclonal antibodies to enhance neutralizing antibodies in a woman on anti-CD20 treatment with refractory COVID-19.

Yusuke Miyazato et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.